The current status of minimal residual disease assessment in myeloma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/leu2013306.pdf
Reference19 articles.
1. Barlogie B, Crowley J . Could CR mean cure? Blood 2011; 118: 483.
2. Rajkumar SV . Treatment of myeloma: cure vs control. Mayo Clin Proc 2008; 83: 1142–1145.
3. Hari P, Pasquini MC, Vesole DH . Cure of multiple myeloma—more hype, less reality. Bone Marrow Transplant 2006; 37: 1–18.
4. Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A et al. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia 1999; 13: 1825–1832.
5. Kumar SK, Flinn I, Noga SJ, Hari P, Rifkin R, Callander N et al. Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study. Leukemia 2010; 24: 1350–1356.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution;Clinical Cancer Research;2022-02-10
2. Exonic variants in multiple myeloma patients associated with relapsed/ refractory and response to bortezomib regimens;Saudi Journal of Biological Sciences;2022-01
3. cfTrack: Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes: MRD, recurrence, and evolution;2021-11-11
4. Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives;Frontiers in Oncology;2019-08-20
5. A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?;Clinical Case Reports;2019-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3